{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:54:21Z","timestamp":1791298461158,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.neurobiolaging.2008.07.008","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T11:52:50Z","timestamp":1219319570000},"page":"953-968","source":"Crossref","is-referenced-by-count":191,"title":["Cell-produced \u03b1-synuclein oligomers are targeted to, and impair, the 26S proteasome"],"prefix":"10.1016","volume":"31","author":[{"given":"Evangelia","family":"Emmanouilidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Vekrellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0304-4165(95)00122-0","article-title":"Regulatory subunit complex dissociated from 26S proteasome, isolation and characterization","volume":"1245","author":"Akaishi","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(00)01049-1","article-title":"Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells","volume":"285","author":"Ancolio","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease","volume":"295","author":"Auluck","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib4","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1074\/jbc.M412106200","article-title":"Mechanisms of suppression of {alpha}-synuclein neurotoxicity by geldanamycin in Drosophila","volume":"280","author":"Auluck","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib5","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1097-2765(02)00775-X","article-title":"ATP hydrolysis by the proteasome regulatory complex PAN serves multiple functions in protein degradation","volume":"11","author":"Benaroudj","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib7","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin\u2013proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib8","doi-asserted-by":"crossref","first-page":"33855","DOI":"10.1074\/jbc.274.48.33855","article-title":"Degradation of alpha-synuclein by proteasome","volume":"274","author":"Bennett","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0197-4580(97)00164-4","article-title":"A model for structure-dependent binding of Congo red to Alzheimer beta-amyloid fibrils","volume":"19","author":"Carter","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib10","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/hmg\/9.19.2811","article-title":"Mechanisms of chaperone suppression of polyglutamine disease, selectivity, synergy and modulation of protein solubility in Drosophila","volume":"9","author":"Chan","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib12","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1074\/jbc.M413007200","article-title":"Overexpression of proteasome \u03b25 subunit increases the amount of assembled proteasome and confers ameliorated response to oxidative stress and higher survival rates","volume":"280","author":"Chondrogianni","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease, implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib14","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant a-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/502","article-title":"Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1","volume":"19","author":"Cummings","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","article-title":"Widespread alterations of alpha-synuclein in multiple system atrophy","volume":"155","author":"Dickson","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1534\/genetics.104.035493","article-title":"Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast","volume":"170","author":"Dixon","year":"2005","journal-title":"Genetics"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib19","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1073\/pnas.0510496103","article-title":"Hsp70 chaperones accelerate protein translocation and the unfolding of stable protein aggregates by entropic pulling","volume":"103","author":"De Los Rios","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib20","doi-asserted-by":"crossref","first-page":"33182","DOI":"10.1074\/jbc.M606192200","article-title":"Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro","volume":"281","author":"Evans","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications","volume":"55","author":"Farrer","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib22","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1046\/j.1471-4159.2000.0752221.x","article-title":"Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex","volume":"75","author":"Ghee","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib23","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1111\/j.1742-4658.2005.04776.x","article-title":"PA700, the regulatory complex of the 26S proteasome, interferes with a-synuclein assembly","volume":"272","author":"Ghee","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Golberg","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib26","doi-asserted-by":"crossref","first-page":"48984","DOI":"10.1074\/jbc.M208194200","article-title":"Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion","volume":"277","author":"Gosavi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib27","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1073\/pnas.110138997","article-title":"Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules, implications for Huntington's disease therapy","volume":"92","author":"Heiser","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1042\/bj3320749","article-title":"Simultaneous binding of PA28 and PA700 activators to 20S proteasomes","volume":"332","author":"Hendil","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1006\/jmbi.2001.5285","article-title":"26S proteasomes function as stable entities","volume":"315","author":"Hendil","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib30","doi-asserted-by":"crossref","first-page":"16890","DOI":"10.1016\/S0021-9258(19)89473-5","article-title":"Activation of the multicatalytic protease","volume":"269","author":"Hoffman","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib31","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1046\/j.1471-4159.2003.01952.x","article-title":"Dysfunction of mitochondrial complex I and the proteasome, interactions between two biochemical deficits in a cellular model of Parkinson's disease","volume":"86","author":"Hoglinger","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib32","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/sj.emboj.7600426","article-title":"Inefficient degradation of truncated polyglutamine proteins by the proteasome","volume":"23","author":"Holmberg","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/sj.cdd.4401397","article-title":"RAIDD aggregation facilitates apoptotic death of PC12 cells and sympathetic neurons","volume":"11","author":"Jabado","year":"2004","journal-title":"Cell Death Diff."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib34","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1074\/jbc.270.19.11623","article-title":"Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome","volume":"270","author":"Jariel-Encontre","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib35","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0002-9440(10)63072-6","article-title":"Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model","volume":"159","author":"Kahle","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib37","doi-asserted-by":"crossref","first-page":"25497","DOI":"10.1074\/jbc.M400255200","article-title":"Hsp70 reduces alpha-synuclein aggregation and toxicity","volume":"279","author":"Klucken","year":"2004","journal-title":"J Biol Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molcel.2007.04.001","article-title":"Disease-associated prion protein oligomers inhibit the 26S proteasome","volume":"26","author":"Kristiansen","year":"2007","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib39","first-page":"509","article-title":"Ubiquitinated inclusions and neuronal cell death","volume":"18","author":"Lang-Rollin","year":"2003","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib40","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"a-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib41","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","article-title":"Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib42","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","article-title":"Proteasomal inhibition by alpha-synuclein filaments and oligomers","volume":"279","author":"Lindersson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(02)01012-7","article-title":"The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility","volume":"111","author":"Liu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib44","doi-asserted-by":"crossref","first-page":"52984","DOI":"10.1074\/jbc.M409028200","article-title":"\u03b1-Synuclein expresion levels do not significantly affect proteasome function and expression in mice and stably transfected PC12 cell lines","volume":"279","author":"Martin-Clemente","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbrc.2004.07.021","article-title":"Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro","volume":"321","author":"McLean","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib46","doi-asserted-by":"crossref","first-page":"e1867","DOI":"10.1371\/journal.pone.0001867","article-title":"Formation of toxic oligomeric \u03b1-synuclein species in living cells","volume":"3","author":"Outeiro","year":"2008","journal-title":"PLOS One"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib47","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","article-title":"Induction of alpha-synuclein aggregation by intracellular nitrative insult","volume":"21","author":"Paxinou","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib48","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0896-6273(02)01125-X","article-title":"Parkin protects against the toxicity associated with mutant alpha-synuclein, proteasome dysfunction selectively affects catecholaminergic neurons","volume":"36","author":"Petrucelli","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrm1336","article-title":"Proteasomes and their kin, proteases in the machine age","volume":"5","author":"Pickart","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib50","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","article-title":"Proteasomal inhibition leads to formation of ubiquitin\/\u03b1-synuclein immunoreactive inclusions in PC12 cells","volume":"78","author":"Rideout","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/mcne.2002.1173","article-title":"Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination","volume":"21","author":"Rideout","year":"2002","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib52","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0531-5565(02)00127-4","article-title":"Assays of proteasome activity in relation to aging","volume":"37","author":"Rivett","year":"2002","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib53","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1357-2725(02)00391-6","article-title":"Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates","volume":"35","author":"Rodgers","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"Sanchez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib55","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.1074\/jbc.M308434200","article-title":"Proteasome mediates dopaminergic neuronal degeneration and its inhibition causes a-synuclein inclusions","volume":"279","author":"Sawada","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib56","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.06.033","article-title":"Docking of the proteasomal ATPases\u2019 carboxyl termini in the 20S proteasome's a ring opens the gate for substrate entry","volume":"27","author":"Smith","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib58","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1093\/hmg\/ddi396","article-title":"Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutantalpha-synuclein-inducedtoxicity","volume":"14","author":"Smith","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib59","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1074\/jbc.M208641200","article-title":"Aggregated and monomeric alpha-synuclein bind to the S6\u2019 proteasomal protein and inhibit proteasomal function","volume":"278","author":"Snyder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib60","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","article-title":"Expression of A53T mutant but not wild-type a-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death","volume":"21","author":"Stefanis","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib61","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1046\/j.1471-4159.2001.00114.x","article-title":"Synuclein-1 is selectively up-regulated in response to nerve growth factor treatment in PC12 cells","volume":"76","author":"Stefanis","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/abbi.1999.1584","article-title":"Isolation and characterization of a novel 530-kDa protein complex (PC530. capable of associating with the 20S proteasome from Starfish oocytes","volume":"374","author":"Tanaka","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib63","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/10.9.919","article-title":"Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis","volume":"10","author":"Tanaka","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0014-5793(01)03115-5","article-title":"Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome","volume":"509","author":"Tofaris","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib65","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(94)90502-9","article-title":"Ubiquitin-dependent c-jun degradation in vivo is mediated by the delta domain","volume":"78","author":"Treier","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib66","doi-asserted-by":"crossref","unstructured":"Tseng, B.P., Green, K.N., Chan, J.L., Blurton-Jones, M., Laferla, F.M., 2007. Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging, 2007, doi:10.1016\/j.neurobiolaging.2007.04.014.","DOI":"10.1016\/j.neurobiolaging.2007.04.014"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/MN:30:1:001","article-title":"Neurobiology of a-synuclein","volume":"30","author":"Vekrellis","year":"2004","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib68","series-title":"Ubiquitin and the proteasome in neurodegeneration","author":"Vekrellis","year":"2005"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib69","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","article-title":"Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease","volume":"42","author":"Volles","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2008.07.008_bib70","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458008002522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458008002522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T08:04:47Z","timestamp":1631693087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458008002522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0197458008002522"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.07.008","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}